Young Researcher from Friendswood Uses AI to Accelerate Frontotemporal Dementia Drug Discovery

In Brief

1. Myreen Ahsan screened over 10 million drug-like molecules using AI.
2. Her research targets frontotemporal dementia treatments.
3. She is a national finalist in a prestigious science competition.
4. Myreen will present her findings later this year in Washington, D.C.

Myreen Ahsan, an eighth-grade student from Friendswood, has made a significant stride in medical research by using artificial intelligence to screen over 10 million drug-like molecules. This innovative work focuses on developing treatments for frontotemporal dementia, a neurodegenerative condition that currently lacks effective therapies.

Her project’s success earned her a place as a national finalist in a well-known science competition. Myreen's use of machine learning demonstrates the growing role of AI in accelerating drug discovery and medical research.

Later this year, she is scheduled to present her findings in Washington, D.C., where her work is expected to inspire both scientific and youth communities. This achievement highlights the impact young researchers can have on critical health challenges.

Myreen’s accomplishment underlines the importance of integrating technology with scientific inquiry to address complex diseases, setting a precedent for future research efforts.